Načítá se...
A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes
BACKGROUND: Several lines of evidence suggest a T cell–mediated immune response in paraneoplastic neurological syndromes with anti-Hu antibodies (Hu-PNS). In order to investigate whether suppression of T cell–mediated immune responses in Hu-PNS patients improved their neurological outcome, we perfor...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483045/ https://ncbi.nlm.nih.gov/pubmed/24994790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou126 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|